A case of post‐COVID‐19 myalgic encephalomyelitis/chronic fatigue syndrome characterized by post‐exertional malaise and low serum acylcarnitine level

Ryuhei Jinushi; Sho Nishiguchi; Sakue Masuda; Akiko Sasaki; Kazuya Koizumi; Shomei Ryozawa

doi:10.1002/ccr3.6930

Clinical Case Reports (Feb 2023)

A case of post‐COVID‐19 myalgic encephalomyelitis/chronic fatigue syndrome characterized by post‐exertional malaise and low serum acylcarnitine level

Ryuhei Jinushi,
Sho Nishiguchi,
Sakue Masuda,
Akiko Sasaki,
Kazuya Koizumi,
Shomei Ryozawa

Affiliations

Ryuhei Jinushi: Department of Gastroenterology Saitama Medical University International Medical Center Hidaka Japan
Sho Nishiguchi: Department of General Internal Medicine Shonan Kamakura General Hospital Kamakura Japan
Sakue Masuda: Department of Gastroenterology Medicine Center Shonan Kamakura General Hospital Kamakura Japan
Akiko Sasaki: Department of Gastroenterology Medicine Center Shonan Kamakura General Hospital Kamakura Japan
Kazuya Koizumi: Department of Gastroenterology Medicine Center Shonan Kamakura General Hospital Kamakura Japan
Shomei Ryozawa: Department of Gastroenterology Saitama Medical University International Medical Center Hidaka Japan

DOI: https://doi.org/10.1002/ccr3.6930
Journal volume & issue: Vol. 11, no. 2
pp. n/a – n/a

Abstract

Read online

Abstract COVID‐19 afflicts patients with acute symptoms and longer term sequelae. One of the sequelae is myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), which is often difficult to diagnose, having no established tests. In this article, we synthesize information from literature reviews on patients with ME/CFS that developed after recovery from COVID‐19.

Published in Clinical Case Reports

ISSN: 2050-0904 (Online)
Publisher: Wiley
Country of publisher: United Kingdom
LCC subjects: Medicine: Medicine (General)
Website: https://onlinelibrary.wiley.com/journal/20500904

About the journal

Abstract

Keywords